Iradimed (IRMD) EBITDA Margin (2013 - 2026)
Iradimed's EBITDA Margin came in at 35.33% for Q3 2026, up 1.30 percentage points from 34.03% a year earlier and up 2.10 percentage points from the prior quarter.
Iradimed (IRMD) EBITDA Margin (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Iradimed reported EBITDA Margin of 34.16%, up 2.07 percentage points year-over-year; for FY2025, it came in at 32.59%, up 1.48 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +30.75 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 31.11% in FY2024 (-0.62 pp), 31.73% in FY2023 (+1.15 pp), 30.58% in FY2022 (+3.73 pp) and 26.84% in FY2021 (+25.01 pp).
- The Q3 2026 figure represents the highest quarterly EBITDA Margin since Q3 2023.
- Year-over-year, EBITDA Margin increased in seven of the last eight quarters, with an average year-over-year change of +1.54 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in Q4 2021 (a gain of 17.86 percentage points), and the weakest in Q4 2022 (a drop of 5.49 percentage points).
- Business Quant data shows IRMD's EBITDA Margin at 33.23% (Q2 2026), 35.00% (Q1 2026) and 32.94% (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 265.71 Bn | 242.23 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 189.37 Bn | 163.23 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 164.78 Bn | 144.43 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 157.85 Bn | 138.13 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 129.66 Bn | 94.91 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 121.82 Bn | 108.01 Bn | 4.25 Bn | 20.38% |
| 7 | Boston Scientific | 63.42 Bn | 58.86 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.49 Bn | 42.69 Bn | 1.35 Bn | 20.05% |
| 9 | Becton Dickinson | 58.38 Bn | 55.53 Bn | 2.32 Bn | 24.62% |
| 10 | Iradimed | 1.11 Bn | 877.45 Mn | 18.46 Mn | 35.33% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.33% |
| Jun 30, 2026 | 33.23% |
| Mar 31, 2026 | 35.00% |
| Dec 31, 2025 | 32.94% |
| Sep 30, 2025 | 34.03% |
| Jun 30, 2025 | 34.28% |
| Mar 31, 2025 | 28.84% |
| Dec 31, 2024 | 30.92% |
| Sep 30, 2024 | 32.67% |
| Jun 30, 2024 | 32.50% |
| Mar 31, 2024 | 28.27% |
| Dec 31, 2023 | 30.74% |
| Sep 30, 2023 | 36.93% |
| Jun 30, 2023 | 31.93% |
| Mar 31, 2023 | 27.07% |
| Dec 31, 2022 | 23.96% |
| Sep 30, 2022 | 34.07% |
| Jun 30, 2022 | 36.64% |
| Mar 31, 2022 | 28.50% |
| Dec 31, 2021 | 29.45% |
Iradimed EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IRMD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IRMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IRMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();